Table 4.
OR for Hip Fracture Associated With Diabetes and Mediating Effect of Comorbidities on Diabetes-Associated Risk
| OR (95% CI) | % of Diabetes Effect Mediated | |
|---|---|---|
| Diabetesa | 1.21 (1.19–1.23) | — |
| + Chronic kidney disease | 1.20 (1.18–1.21) | NS |
| + Neuropathy | 1.16 (1.15–1.18) | 20.0 |
| + Cardiovascular disease | 1.18 (1.17–1.20) | NS |
| + Cerebrovascular disease | 1.21 (1.19–1.22) | NS |
| + Congestive heart failure | 1.18 (1.16–1.19) | NS |
| + Chronic obstructive lung disease | 1.21 (1.19–1.23) | NS |
| + Chronic liver disease | 1.21 (1.19–1.22) | NS |
Abbreviation: NS, not significant.
a
All models were adjusted for age, race/ethnicity, tobacco use, alcohol use, glucocorticoid use, rheumatoid arthritis, and BMI.